Breaking News

NSF Pharmalytica Expands Team

January 24, 2013

Adds six scientists to assist with 510(K) compliance

NSF Pharmalytica has added six scientists specializing in analytical testing, method development and validation to help companies achieve 510(k) compliance. The new team includes: Bethany DePaul, Scientist II, Matthew Johnson, MS, Scientist II, Kerry Medovich, Scientist III, Zemelia Miller, Scientist I, Amanda Pires, Scientist I, and Edie Wagner, Scientist I.
“Helping companies meet FDA compliance to 510(k) by testing for extractables and leachables in medical devices is part of our expertise. Each scientist helps to ensure clients receive effective, timely and cost-effective solutions to all of their testing needs including 510(k),” said Jim Scull, Ph.D., NSF Pharmalytica general manager.
NSF Pharmalytica is part of the Health Sciences Division of NSF International, a global independent public health organization that writes standards, and tests and certifies products for the health sciences, water, food, and consumer goods industries.

Related Contract Manufacturing:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks